[Resistance of Listeria monocytogenes to cefotaxime and ceftriaxone combined with an aminoside]. 1987

E Borderon, and J C Borderon, and J F Feron, and J C Thieffry, and M Tescher, and I A Farid

The in vitro antibacterial activity of cefotaxime and ceftriaxone-aminoglycoside combinations was studied against 20 clinical isolates of Listeria monocytogenes, and compared with the activity of the antibiotics alone. Minimal bacteriostatic and bactericidal concentrations (MBCs) as well as killing curves were determined using different parameters. In all cases, the MBCs of gentamicin and netilmicin were shown to be lowered by addition of CTX or CTR. Using Mueller-Hinton broth the values of MBCs obtained were achievable in the CSF. However, the clinical bearing of these results remained to be discussed.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008089 Listeria monocytogenes A species of gram-positive, rod-shaped bacteria widely distributed in nature. It has been isolated from sewage, soil, silage, and from feces of healthy animals and man. Infection with this bacterium leads to encephalitis, meningitis, endocarditis, and abortion.
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D002443 Ceftriaxone A broad-spectrum cephalosporin antibiotic and cefotaxime derivative with a very long half-life and high penetrability to meninges, eyes and inner ears. Benaxona,Cefatriaxone,Cefaxona,Ceftrex,Ceftriaxon,Ceftriaxon Curamed,Ceftriaxon Hexal,Ceftriaxona Andreu,Ceftriaxona LDP Torlan,Ceftriaxone Irex,Ceftriaxone Sodium,Ceftriaxone Sodium, Anhydrous,Ceftriaxone, Disodium Salt,Ceftriaxone, Disodium Salt, Hemiheptahydrate,Lendacin,Longacef,Longaceph,Ro 13-9904,Ro-13-9904,Ro13-9904,Rocefalin,Rocefin,Rocephin,Rocephine,Tacex,Terbac,Anhydrous Ceftriaxone Sodium,Ro 13 9904,Ro 139904,Ro13 9904,Ro139904
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000617 Aminoglycosides Glycosylated compounds in which there is an amino substituent on the glycoside. Some of them are clinically important ANTIBIOTICS. Aminoglycoside
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

E Borderon, and J C Borderon, and J F Feron, and J C Thieffry, and M Tescher, and I A Farid
August 1982, Canadian Medical Association journal,
E Borderon, and J C Borderon, and J F Feron, and J C Thieffry, and M Tescher, and I A Farid
April 1992, Antimicrobial agents and chemotherapy,
E Borderon, and J C Borderon, and J F Feron, and J C Thieffry, and M Tescher, and I A Farid
June 2024, Open forum infectious diseases,
E Borderon, and J C Borderon, and J F Feron, and J C Thieffry, and M Tescher, and I A Farid
January 1981, Chemotherapy,
E Borderon, and J C Borderon, and J F Feron, and J C Thieffry, and M Tescher, and I A Farid
January 1983, Advances in experimental medicine and biology,
E Borderon, and J C Borderon, and J F Feron, and J C Thieffry, and M Tescher, and I A Farid
November 1996, Pathologie-biologie,
E Borderon, and J C Borderon, and J F Feron, and J C Thieffry, and M Tescher, and I A Farid
October 2019, Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia,
E Borderon, and J C Borderon, and J F Feron, and J C Thieffry, and M Tescher, and I A Farid
August 1990, Lancet (London, England),
E Borderon, and J C Borderon, and J F Feron, and J C Thieffry, and M Tescher, and I A Farid
January 2003, Acta microbiologica Polonica,
E Borderon, and J C Borderon, and J F Feron, and J C Thieffry, and M Tescher, and I A Farid
January 1989, Acta microbiologica Hungarica,
Copied contents to your clipboard!